期刊簡介 | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | International Journal of Pharmaceutics LetPub Score 8.0
50 ratings
Rate
Reputation 8.7 Influence 7.2 Speed 9.0 | ||||||||||||||||
期刊簡稱 | INT J PHARMACEUT | ||||||||||||||||
ISSN | 0378-5173 | ||||||||||||||||
E-ISSN | 1873-3476 | ||||||||||||||||
h-index | 190 | ||||||||||||||||
CiteScore |
| ||||||||||||||||
自引率 (2023-2024) | 7.50%自引率趨勢 | ||||||||||||||||
掲載範囲 |
| ||||||||||||||||
官方網站 | https://www.journals.elsevier.com/international-journal-of-pharmaceutics | ||||||||||||||||
在線稿件提交 | https://www.editorialmanager.com/IJPHARM | ||||||||||||||||
開放訪問 | No | ||||||||||||||||
出版商 | Elsevier | ||||||||||||||||
主題領域 | 医学 | ||||||||||||||||
出版國/地區 | NETHERLANDS | ||||||||||||||||
發行頻率 | 隔週刊行 | ||||||||||||||||
創刊年 | 1978 | ||||||||||||||||
每年文章數 | 988每年文章數趨勢 | ||||||||||||||||
黃金OA百分比 | 20.47% | ||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q1
| ||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Science Citation Index Expanded | ||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0378-5173%5BISSN%5D | ||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: About 2.5 month(s) 來自Elsevier的數據: Average 4.8 Week(s) | ||||||||||||||||
競爭力 * | 來自作者的數據: About 75% 來自Elsevier的數據: 31% | ||||||||||||||||
在線文章發布時間 | 來自Elsevier的數據: Average 4.6 Week(s) | ||||||||||||||||
參考鏈接 |
| ||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 2 3 4 下一頁 末頁 (頁 | |
[International Journal of Pharmaceutics] 的評論 | 撰寫評論 |
作者: sqwudmty 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-06-16 08:34:07 評論於 Is there really no one sending emails to criticize the editor?(0) 讚! | sqwudmty |
作者: sqwudmty 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-06-16 07:47:40 評論於 Japanese editors review submissions the day after they are submitted. On the same day, there is a reviewer who accepts the submission. The review feedback is usually returned within 20 days, with the editor providing 20 suggestions for revisions. However, even after 10 days of making the revisions, the submission is still with the same editor and has not been sent for further review(0) 讚! | sqwudmty |
作者: 无情臭猪 領域: 材料科学 審稿時間: 1.0 month(s) 結果: 修改後接受 撰寫評論 |
2024-05-09 21:48:38 評論於 The direction of drug delivery is smooth, the review was done quickly, and the reviewers' questions were also very professional. It took over a month to make revisions(0) 讚! | 无情臭猪 |
作者: 书生梦幻 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-04-07 22:30:51 評論於 Research focus: Targeted drugs; Pharmacy experience sharing: Rejected for 6 days, Japanese editor(0) 讚! | 书生梦幻 |
作者: 药大密探007 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-03-24 23:34:43 評論於 Can I collect the prescription drugs?(0) 讚! | 药大密探007 |
作者: Patrick Tracy 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-03-18 23:10:53 評論於 Hello, where can I find the submission format requirements? I couldn't find it on the official website(0) 讚! | Patrick Tracy |
作者: 平原爱梅 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-02-26 13:47:35 評論於 Hello! Have you received a reply yet? What is the decision? Can you please share?(0) 讚! | 平原爱梅 |
作者: Geraldine Wycliffe 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-01-01 17:57:44 評論於 How long will the decision in process take, and what is the next stage?(0) 讚! | Geraldine Wycliffe |
作者: 北海冬烟 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-12-27 13:16:35 評論於 Oh, how unlucky! I am a Japanese editor Fumiyoshi Yamashita who has just been assigned. Hopefully it won't be unfriendly! Sigh! Let's wait patiently!(0) 讚! | 北海冬烟 |
作者: Wlh 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-12-18 14:52:57 評論於 It has been 20 days since the first return for repair with Required Reviews Completed status, and the date has changed once. What is the reason for this?(0) 讚! | Wlh |
作者: 五郎嘉悦 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-10-25 14:52:36 評論於 How long will the DIP take, has it been submitted for review yet?(0) 讚! | 五郎嘉悦 |
作者: 月河海霞 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-10-17 17:57:02 評論於 Sigh... me too, I didn't choose the editor from Japan, but he was still assigned. The decision is still in process. Why can't they just make a clear decision?(0) 讚! | 月河海霞 |
作者: 玉萧半青 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-06-09 12:04:17 評論於 Japanese editing is really... it's been almost two weeks, still not reviewed, they want to reject it, speechless(0) 讚! | 玉萧半青 |
作者: 暴风晨钰 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-03-22 17:44:03 評論於 This Japanese editor is very unfriendly(0) 讚! | 暴风晨钰 |
作者: 华清雨荷 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-03-04 15:03:35 評論於 Do not pitch this one, it's a huge waste of time. I was assigned to the Japanese editor for over two weeks, it never got reviewed and was ultimately rejected directly(0) 讚! | 华清雨荷 |
作者: 庆彦mm 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-11-06 22:06:48 評論於 Hello, do the reviewers have to find themselves?(0) 讚! | 庆彦mm |
作者: 海伦郎 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-10-06 13:12:04 評論於 Review speed: 1.0 | Submission acceptance rate: 75.0 Emphasized research direction: Nano drugs; Liposome experience sharing: Submitted on August 1st, sent for review on August 9th, received initial review comments on August 28th. Three reviewers were quite friendly, added a hemolysis experiment, retook electron microscope images, and made minor grammar corrections. Returned to the journal for revisions on September 13th. Second review comments returned on October 4th, requiring minor revisions. Completed and submitted the revisions on the 5th, and accepted by a Korean editor on October 6th, who was very friendly. Two articles from his lab have been accepted(0) 讚! | 海伦郎 |
作者: 极乐幻梅 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-05-31 21:24:17 評論於 Pretty fast, I submitted two papers to IJP and EJPB respectively. IJP was revised once and took a total of two months to go online; EJPB was revised once and took about four months in total(0) 讚! | 极乐幻梅 |
作者: 南风卫镇 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-05-16 10:24:36 評論於 Do you have a template for this journal?(0) 讚! | 南风卫镇 |
作者: 明冠半芙 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-05-05 11:02:59 評論於 Is this magazine fast?(0) 讚! | 明冠半芙 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 18:08:03 評論於 Please translate the following paragraph into English and Japanese(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 11:00:28 評論於 Keywords are often the most frequently used words in a text. Keywords are words that can represent the essence of your paper, making it easier to find and increasing the chances of citation(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 魂魄彦露 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-27 23:14:01 評論於 What is the maximum number of keywords that can be used?(0) 讚! | 魂魄彦露 |
作者: Oswald Edie 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-27 10:33:37 評論於 What are the requirements for keyword filtering?(0) 讚! | Oswald Edie |
作者: 药剂搬运工 領域: 医学 審稿時間: 3.0 month(s) 結果: 修改後接受 撰寫評論 |
2021-12-02 14:07:20 評論於 Before the Chinese New Year, I wrote a comprehensive review on crystallography. I encountered three reviewers. The first reviewer was particularly unfriendly and rejected the paper without even reading it in detail. Fortunately, the following two reviewers provided very positive feedback. We responded to all three reviewers with well-founded arguments. After an anxious wait, we successfully accepted the paper.(2) 讚! | 药剂搬运工 |
首頁 上一頁 1 2 3 4 下一頁 末頁 (頁 |
Contact us